benylan 1,4 mg/ml oral opløsning
mcneil denmark aps - diphenhydraminhydrochlorid - oral opløsning - 1,4 mg/ml
benylan 2,8 mg/ml oral opløsning
mcneil denmark aps - diphenhydraminhydrochlorid - oral opløsning - 2,8 mg/ml
coldycof 1,4 mg/ml oral opløsning
orifarm generics a/s - diphenhydraminhydrochlorid - oral opløsning - 1,4 mg/ml
coldycof 2,8 mg/ml oral opløsning
orifarm generics a/s - diphenhydraminhydrochlorid - oral opløsning - 2,8 mg/ml
paclitaxel "accord" 6 mg/ml koncentrat til infusionsvæske, opløsning
accord healthcare b.v. - paclitaxel - koncentrat til infusionsvæske, opløsning - 6 mg/ml
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - andre narkotika stoffer - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
wakix
bioprojet pharma - pitolisant - narkolepsi - andre narkotika stoffer - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.
stelfonta
qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - hunde - til behandling af ikke-resectable, ikke-metastatisk (der iscenesættelse) subkutan mast celle tumorer er placeret på eller distalt for den albue eller haseleddet, og ikke-resectable, ikke-metastatisk kutan mast celle tumorer hos hunde.
arlevert 20+40 mg tabletter
hennig arzneimittel ag - cinnarizin, dimenhydrinat - tabletter - 20+40 mg
lunsumio
roche registration gmbh - mosunetuzumab - lymfom, follikulært - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.